WO1999037308A1 - Procede pour la preparation d'une forme medicamenteuse se dissolvant rapidement dans la bouche et contenant de l'acarbose comme principe actif - Google Patents
Procede pour la preparation d'une forme medicamenteuse se dissolvant rapidement dans la bouche et contenant de l'acarbose comme principe actif Download PDFInfo
- Publication number
- WO1999037308A1 WO1999037308A1 PCT/EP1999/000131 EP9900131W WO9937308A1 WO 1999037308 A1 WO1999037308 A1 WO 1999037308A1 EP 9900131 W EP9900131 W EP 9900131W WO 9937308 A1 WO9937308 A1 WO 9937308A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acarbose
- mouth
- producing
- medicament
- active agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Definitions
- Acarbose is the first representative of the class of alpha-glucosidase inhibitors, which, by inhibiting the alpha-glucosidase enzymes, delays the cleavage of sucrose, dextrin and starches in the intestine and thus smoothes the blood sugar level
- the method according to the invention describes the composition and production of rapidly disintegrating tablets which dissolve in the mouth by contact with the saliva
- the active ingredient is granulated alone or with parts of the filler with the aid of dry compaction and sieving and compressed to flat wafers on a conventional tablet press
- Particularly suitable fillers are water-insoluble auxiliaries, for example calcium phosphate or microcrystalline cellulose
- the proportion of the active ingredient in the formulation is preferably 40-90%, the proportion of fillers and auxiliaries 10-60%.
- Acarbose, milk sugar and microcrystalline cellulose are mixed in a suitable container.
- the cross-linked polyvinylpyrollidone and the magnesium stearate are added and mixed again.
- the ready-to-press mixture is pressed on a conventional tablet press into tablets which have a diameter of 12 mm.
- the height of the tablets is less than 2 mm.
- the tablet disintegrates in less than 2 minutes.
- Acarbose, calcium hydrogen phosphate and sodium bicarbonate are mixed in a suitable container. After dry compaction and subsequent sieving, the citric acid is added.
- the ready-to-press mixture is compressed in a conventional tablet press to tablets which have a diameter of 12 mm.
- the height of the tablets is less than 2 mm.
- the tablet disintegrates in less than 2 minutes.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25171/99A AU2517199A (en) | 1998-01-24 | 1999-01-12 | Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998102700 DE19802700A1 (de) | 1998-01-24 | 1998-01-24 | Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält |
DE19802700.1 | 1998-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999037308A1 true WO1999037308A1 (fr) | 1999-07-29 |
Family
ID=7855589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/000131 WO1999037308A1 (fr) | 1998-01-24 | 1999-01-12 | Procede pour la preparation d'une forme medicamenteuse se dissolvant rapidement dans la bouche et contenant de l'acarbose comme principe actif |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2517199A (fr) |
DE (1) | DE19802700A1 (fr) |
WO (1) | WO1999037308A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070227A1 (fr) * | 2002-02-21 | 2003-08-28 | Lts Lohmann Therapie-Systeme Ag | Preparation pharmaceutique a gout masque se presentant sous la forme de films ou de plaques |
WO2011134962A3 (fr) * | 2010-04-27 | 2012-05-03 | Bayer Pharma Aktiengesellschaft | Comprimé à désintégration orale contenant de l'acarbose |
KR101421330B1 (ko) * | 2008-12-17 | 2014-07-18 | 사토 세이야쿠 가부시키가이샤 | 붕괴정 |
CN104013590A (zh) * | 2014-05-09 | 2014-09-03 | 万特制药(海南)有限公司 | 一种含阿卡波糖的药物组合物及其制备方法 |
WO2016097170A1 (fr) * | 2014-12-17 | 2016-06-23 | Empros Pharma Ab | Composition à libération modifiée d'orlistat et d'acarbose pour le traitement d'obésité et de troubles métaboliques associés |
WO2018064795A1 (fr) * | 2016-10-05 | 2018-04-12 | Boai Nky Pharmaceuticals Ltd. | Compositions de comprimés contenant de la polyvinylpyrrolidone réticulée et leur utilisation dans des applications de boisson |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2367900A (en) * | 1998-12-18 | 2000-07-03 | Bayer Corporation | Chewable drug delivery system |
RU2010128019A (ru) * | 2007-12-08 | 2012-01-20 | Байер Шеринг Фарма Акциенгезельшафт (DE) | Пероральная диспергируемая таблетка |
TR201100150A2 (tr) * | 2011-01-06 | 2012-07-23 | Bi̇lgi̇ç Mahmut | Suda çözünür dozaj formları |
WO2013115745A1 (fr) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Procédé de préparation de compositions pharmaceutiques (effervescentes) contenant un inhibiteur de l'apha-glucosidase (p. ex. voglibose) et de la metformine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0226121A2 (fr) * | 1985-12-13 | 1987-06-24 | Bayer Ag | Composition contenant de l'acarbose très pure |
EP0638317A1 (fr) * | 1993-08-05 | 1995-02-15 | F. Hoffmann-La Roche Ag | Composition pharmaceutique |
-
1998
- 1998-01-24 DE DE1998102700 patent/DE19802700A1/de not_active Withdrawn
-
1999
- 1999-01-12 WO PCT/EP1999/000131 patent/WO1999037308A1/fr not_active Application Discontinuation
- 1999-01-12 AU AU25171/99A patent/AU2517199A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0226121A2 (fr) * | 1985-12-13 | 1987-06-24 | Bayer Ag | Composition contenant de l'acarbose très pure |
EP0638317A1 (fr) * | 1993-08-05 | 1995-02-15 | F. Hoffmann-La Roche Ag | Composition pharmaceutique |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070227A1 (fr) * | 2002-02-21 | 2003-08-28 | Lts Lohmann Therapie-Systeme Ag | Preparation pharmaceutique a gout masque se presentant sous la forme de films ou de plaques |
US7615235B2 (en) | 2002-02-21 | 2009-11-10 | Lts Lohmann Therapie-Systeme Ag | Film-shaped or wafer-shaped pharmaceutical preparation with masked taste |
KR101421330B1 (ko) * | 2008-12-17 | 2014-07-18 | 사토 세이야쿠 가부시키가이샤 | 붕괴정 |
WO2011134962A3 (fr) * | 2010-04-27 | 2012-05-03 | Bayer Pharma Aktiengesellschaft | Comprimé à désintégration orale contenant de l'acarbose |
CN104013590A (zh) * | 2014-05-09 | 2014-09-03 | 万特制药(海南)有限公司 | 一种含阿卡波糖的药物组合物及其制备方法 |
CN107405309A (zh) * | 2014-12-17 | 2017-11-28 | 安普洛德制药公司 | 用于治疗肥胖症和相关代谢紊乱的奥利司他和阿卡波糖的调释组合物 |
WO2016097170A1 (fr) * | 2014-12-17 | 2016-06-23 | Empros Pharma Ab | Composition à libération modifiée d'orlistat et d'acarbose pour le traitement d'obésité et de troubles métaboliques associés |
CN107405309B (zh) * | 2014-12-17 | 2019-04-16 | 安普洛德制药公司 | 用于治疗肥胖症和相关代谢紊乱的奥利司他和阿卡波糖的调释组合物 |
EA033448B1 (ru) * | 2014-12-17 | 2019-10-31 | Empros Pharma Ab | Композиция орлистата и акарбозы с модифицированным высвобождением для лечения ожирения и связанных метаболических нарушений |
US10561617B2 (en) | 2014-12-17 | 2020-02-18 | Empros Pharma Ab | Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders |
EP3943076A3 (fr) * | 2014-12-17 | 2022-04-13 | Empros Pharma AB | Composition à libération modifiée d'orlistat et d'acarbose pour le traitement de l'obésité |
US11975105B2 (en) | 2014-12-17 | 2024-05-07 | Empros Pharma Ab | Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders |
WO2018064795A1 (fr) * | 2016-10-05 | 2018-04-12 | Boai Nky Pharmaceuticals Ltd. | Compositions de comprimés contenant de la polyvinylpyrrolidone réticulée et leur utilisation dans des applications de boisson |
CN109803931A (zh) * | 2016-10-05 | 2019-05-24 | 博爱新开源医疗科技集团股份有限公司 | 含有交联聚乙烯吡咯烷酮的片剂组合物及其在饮料应用中的用途 |
US11535740B2 (en) | 2016-10-05 | 2022-12-27 | Boai Nky Medical Holdings Ltd. | Tablet compositions containing crosslinked polyvinylpyrrolidone and their use in beverage applications |
Also Published As
Publication number | Publication date |
---|---|
AU2517199A (en) | 1999-08-09 |
DE19802700A1 (de) | 1999-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60032691T2 (de) | Brausetablette für die sublinguale, bukkale und gingivale verabreichung von fentanyl | |
US5223264A (en) | Pediatric effervescent dosage form | |
EP0525388B1 (fr) | Comprimé à sucer ou à mâcher | |
US6284272B1 (en) | Pharmaceutical compositions containing an effervescent acid-base couple | |
DE69821553T2 (de) | Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat | |
DE2551280A1 (de) | L-dopa-zubereitung | |
DE2527534A1 (de) | Enzymhaltige reinigungstablette fuer kuenstliche gebisse | |
WO1999037308A1 (fr) | Procede pour la preparation d'une forme medicamenteuse se dissolvant rapidement dans la bouche et contenant de l'acarbose comme principe actif | |
EP0998932A1 (fr) | Forme d'administration pharmaceutique contenant des diphosphonates ou leurs sels et méthode pour la fabriquer | |
EP0673245A1 (fr) | Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation. | |
EP0759296B1 (fr) | Composition pharmaceutique de tramadol ou d'un sel de tramadol à délitement rapide | |
EP0804171A1 (fr) | Comprime a macher a action effervescente | |
DE3727615C2 (de) | Pharmazeutische Zubereitung für die Fluorid- und Calciumionen-Versorgung | |
EP0717614B1 (fr) | Granulat effervescent et son procede de preparation | |
CH652025A5 (de) | Pharmazeutisches praeparat. | |
EP0687464A2 (fr) | Procédé de fabrication de comprimés effervescents et comprimés effervescents | |
US3976601A (en) | Water soluble lubricant for tabletting compositions | |
DE69108022T2 (de) | Arzneimittel. | |
DE60205125T2 (de) | Feste zubereitungen mit ramipril | |
EP0625355B1 (fr) | Comprimé à biodisponibilité améliorée contenant l'acide dichlorométhylène-diphosphonique en tant qu'ingrédient actif | |
EP0471967A1 (fr) | Comprimé à mâcher à base de sucralfate | |
DE60306747T2 (de) | Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion | |
DE19740983A1 (de) | Verfahren zur Erschwerung der Extraktion von Wirkstoffen aus Tabletten | |
DE1938709A1 (de) | Neue Antibiotika-haltige Zusammensetzungen | |
EP0749304B2 (fr) | Comprime a effet retard contenant du diclofenac-na |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999904766 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999904766 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |